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PHAGOCYTES
1,25-dihydroxyvitamin D3 is a potent suppressor of interferon –mediated
macrophage activation
Laura Helming, Jens Bo¨se, Jan Ehrchen, Stefanie Schiebe, Thomas Frahm, Robert Geffers, Michael Probst-Kepper, Rudi Balling,
and Andreas Lengeling
1,25-dihydroxyvitamin D3 (1,25(OH)2D3),
the activated vitamin D3 hormone, is a key
regulator of calcium homeostasis and
thereby indispensable for bone metabo-
lism. In addition, 1,25(OH)2D3 is known
to mediate predominantly immunosup-
pressive responses in vitro and in vivo. It
has been demonstrated that macrophages
can produce 1,25(OH)2D3 on activation
with interferon  (IFN-), although little is
understood about the biologic signifi-
cance of this response. We show here
that 1,25(OH)2D3 can selectively sup-
press key effector functions of IFN-–
activated macrophages. Among these are
the suppression of listericidal activity, the
inhibition of phagocyte oxidase-mediated
oxidative burst, and the suppression of
important IFN-–induced genes, includ-
ing Ccl5, Cxcl10, Cxcl9, Irf2, Fcgr1, Fcgr3,
and Tlr2. The deactivation of IFN-–
stimulated macrophages is dependent on
a functional vitamin D receptor and
1,25(OH)2D3 acts specifically on IFN-–
activated macrophages, whereas the ste-
roid has no effects on resting macro-
phages. Therefore, the 1,25(OH)2D3–
mediated suppression of macrophage
functions is distinct from previously de-
scribed macrophage deactivation mecha-
nisms. In conclusion, our data indicate
that the production of 1,25(OH)2D3 by
IFN-–stimulated macrophages might be
an important negative feedback mecha-
nism to control innate and inflammatory
responses of activated macrophages.
(Blood. 2005;106:4351-4358)
© 2005 by The American Society of Hematology
Introduction
The steroid hormone 1,25-dihydroxyvitamin D3 (1,25(OH)2D3)
is known for its important role in regulating calcium homeostasis
and bone mineralization.1 1,25(OH)2D3 acts through a nuclear
receptor, the vitamin D receptor (Vdr), which is a member of the
steroid and thyroid hormone receptor superfamily. More recently,
evidence has accumulated that the hormone can have important
functions in the immune system. Expression of Vdr was found in
different immune effector cells of the myeloid and lymphoid
lineage under resting and activating conditions.2,3 These findings
contributed to the hypothesis that locally produced 1,25(OH)2D3
may perform regulatory functions on those cells. Indeed, over the
past few years it has been demonstrated that 1,25(OH)2D3 can act
as an important immunosuppressive modulator. 1,25(OH)2D3 has
been shown to suppress T-cell proliferation4 and to decrease the
production of the T helper type 1 (Th1) cytokines interleukin 2,
interferon  (IFN-), and tumor necrosis factor  (TNF-), leading
to the inhibition of Th1 cell development.5 Besides its direct effects
on T cells, 1,25(OH)2D3 and its analogs are potent inhibitors of
dendritic cell (DC) differentiation and maturation and can impair
the capacity of DCs to induce alloreactive T-cell activation.6,7 In
line with this, Vdr-deficient mice have been shown to have an
increased frequency of mature DCs in lymph nodes.8 Additional
support for the immunomodulatory role of 1,25(OH)2D3 in vivo
came from studies of autoimmune diseases in several different
animal models. It has been demonstrated that 1,25(OH)2D3 can
prevent or suppress experimental autoimmune encephalomyelitis,9
rheumatoid arthritis,10 systemic lupus erythematosus,11 type 1
diabetes,12 and inflammatory bowel disease,13,14 further supporting
its potent suppressive effects on the immune system.
In contrast to its well-characterized effects on adaptive immune
responses, much less is known about the effects of 1,25(OH)2D3
on effectors of innate immunity, especially on macrophages. It has
been shown that 1,25(OH)2D3 can induce the differentiation of
myeloid progenitors into macrophages.15,16 However, the effects of
1,25(OH)2D3 on mature and activated macrophages that are
involved in inflammatory reactions have not been characterized
yet. Such possible effects might be of especial importance since it
was demonstrated that macrophages can release biologically active
1,25(OH)2D3 on activation with IFN-.17,18 The production of
1,25(OH)2D3 by activated macrophages is regulated by the
IFN-–mediated induction of 1-hydroxylase expression, the
enzyme controlling the last step of 1,25(OH)2D3 synthesis.17,18 In
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granulomatous diseases, such as sarcoidosis and tuberculosis,
dysregulated production of 1,25(OH)2D3 by activated macro-
phages can lead to hypercalcemia due to elevated levels of
circulating 1,25(OH)2D3 in the serum of patients.19,20 Because the
differentiation of myeloid precursors into mature macrophages is
associated with a down-regulation of Vdr expression, it has been
hypothesized that the macrophage-derived 1,25(OH)2D3 acts
principally on other immune effector cells such as T cells, DCs, and
monocytes but not on mature macrophages themselves.21,22
Here, we show that treatment of mature, primary murine
macrophages with IFN- and 1,25(OH)2D3 induces a synergistic
up-regulation of Vdr mRNA expression and a subsequent accumu-
lation of the Vdr protein in the cell nucleus. Under these conditions,
1,25(OH)2D3 exerts strong suppressive effects on IFN-–
stimulated macrophages, which include the inhibition of listericidal
activity and suppression of oxidative burst. The effects depend on
the 1,25(OH)2D3 concentration and on a functional Vdr but are
not present in nonactivated or lipopolysaccharide (LPS)–activated
macrophages. Moreover, 1,25(OH)2D3 treatment of IFN-–
stimulated macrophages inhibits the expression of important IFN-
–induced genes (eg, Ccl5, Cxcl16, Cxcl10, Cxcl9, Irf2, Ifi203,
Fcgr1, Fcgr3, Tlr2). These findings demonstrate a new negative
feedback mechanism of 1,25(OH)2D3 on inflammatory macro-
phage reactions and have a potential application for the future
design of anti-inflammatory therapies.
Materials and methods
Reagents
Recombinant murine IFN- was purchased from PeproTech (London,
United Kingdom). Recombinant murine macrophage colony-stimulating
factor (M-CSF), 1,25(OH)2D3, 4-nitroblue-tetrazoliumchlorid (NBT),
phorbol 12-myristate 13-acetate (PMA), and safranin O were from Sigma-
Aldrich (Munich, Germany); gentamicin was obtained from Invitrogen
(Karlsruhe, Germany). IFN- was diluted in phosphate-buffered saline
(PBS) and used at a final concentration of 500 U/mL. 1,25(OH)2D3 was
initially dissolved in ethanol and added to the cell culture medium at a
dilution of 1:1000 (final concentrations of 0.04, 0.4, 4, 40 nM), whereas
the controls included the respective amounts of ethanol.
Mice and bacteria
C57BL/6 mice were purchased from Harlan (Borchen, Germany) and bred
in the animal facilities of the German Research Center for Biotechnology
(GBF). Vdr tm1 Rge knockout mice23 were obtained from Reinhold Erben
(Vienna, Austria) and maintained on a C57BL/6 background. Listeria
monocytogenes (L monocytogenes) and the listeriolysin (hly)–deficient
listeriolysin mutant24 were grown in brain-heart infusion broth (BHI; Difco,
Becton Dickinson, Baltimore, MD).
Macrophage isolation
Bone marrow-derived macrophages (BMDMs) were differentiated from
bone marrow cells of 8- to 14-week-old mice. Briefly, femora and tibia of
the hind legs were flushed with cold Dulbecco modified Eagle medium
(DMEM; Invitrogen) containing 10% heat-inactivated fetal calf serum
(FCS; Biowest, Nuaille´, France), 200 mM L-glutamine, and 10 000 U/mL
penicillin/streptomycin (P/S; Invitrogen). This complete medium was
supplemented with M-CSF (50 ng/mL) and bone marrow cells were
cultured for 7 days. Thioglycolate-elicited macrophages were obtained 4
days after the intraperitoneal injection of sterile 3% thioglycolate medium.
Cells were harvested by peritoneal lavage with cold PBS and 1% FCS and
were cultured in RPMI 1640 (Invitrogen) including 10% heat-inactivated
FCS, L-glutamine, and P/S.
Determination of listericidal activity
Macrophages were plated at 8 104/well in 96-well plates and cultured in
P/S-free medium in the presence or absence of IFN-, 1,25(OH)2D3, or both for
24 and 48 hours. Cells were infected with L monocytogenes at a multiplicity of
infection (MOI) of 0.1 for 15 minutes. When specifically indicated, infection
experiments were performed with L monocytogenes that were opsonized in 10%
mouse serum from C57BL/6J mice for 10 minutes. Extracellular growth of L
monocytogenes after infection was prevented by the addition 10 g/mL
gentamicin and numbers of intracellular bacteria were determined after 1 and 3
hours. Macrophages were lysed in PBS containing 1% saponin and intracellular
bacteria were quantified by counting the number of colony forming units (CFUs)
in the lysate on BHI plates.Alternatively, macrophages grown on coverslips were
infected with L monocytogenes and fixed with 4% paraformaldehyde (PFA) in
PBS for 15 minutes on ice. Coverslips were then stained using the Hemacolor kit
(Merck, Darmstadt, Germany) according to the supplied protocol.
Measurements of reactive oxygen species by the NBT
reduction assay
BMDMs were plated at 2.5 105/well in 24-well plates or grown on coverslips.
Cells were cultured in the presence or absence of IFN-, 1,25(OH)2D3, or both
for 48 hours, washed, and cultured for 1 hour in serum-free DMEM supple-
mented with 0.1% NBT in the presence or absence of PMA (170 ng/mL). Cells
grown on coverslips were fixed for 15 minutes with 4% PFA and nuclei were
counterstained for 30 seconds by safranin O (0.1% in PBS). For photometrical
quantification, cells were fixed in 100% methanol (15 minutes) and washed twice
in 70% methanol and plates were dried at room temperature. The fixed cells were
homogenized in 62.5 L 2 M KOH and 75 L dimethyl sulfoxide per well, and
the OD650 of 100L of the cell lysate was determined.
RNA isolation, gene expression profiling, and quantitative
RT-PCR
RNA was isolated using TRIzol reagent (Invitrogen). For biotin-labeled
target synthesis starting from 3 g total RNA, reactions were performed
using standard protocols supplied by the manufacturer (Affymetrix; Santa
Clara, CA). Briefly, 3 g total RNA was converted to dsDNA using 100
pmol of a T7T23V primer (Eurogentec; Seraing, Belgium) containing a T7
promoter. The cDNA was then used directly in an in vitro transcription
reaction in the presence of biotinylated nucleotides. The concentration of
biotin-labeled cRNA was determined by UV absorbance. In all cases, 12.5
g of each biotinylated cRNA preparation was fragmented and placed in a
hybridization cocktail containing 4 biotinylated hybridization controls
(BioB, BioC, BioD, and Cre) as recommended by the manufacturer.
Samples were hybridized to an identical lot of Affymetrix MOE430A for 16
hours. Analysis was done with gene expression software (MAS5, MicroDB
and Data Mining Tool 3.0, all Affymetrix) at the Array Facility of the
German Research Center for Biotechnology. The Genesis software package
was applied for the generation of heat maps and cluster analysis (http://
genome.tugraz.at).25 Gene expression profiling data were deposited at the
GEO repository under the accession number GSE2421.
For reverse transcription-polymerase chain reaction (RT-PCR), 1 g
RNA was reverse transcribed using random hexamers (Amersham Bio-
science, Freiburg, Germany) and Superscript II RNase H Reverse
Transcriptase (Invitrogen). Real-time quantitative PCR was performed on
an Applied Biosystems RT-PCR System (PRISM T 7000) using the Brilliant
SYBR Green QPCR Core Reagent Kit (Stratagene, La Jolla, CA).
Expression was normalized to housekeeping genes (Rps9 or Gapdh) and to
unstimulated wild-type controls. Oligonucleotide primers used for amplifi-
cation are listed in the Table S1 (available on the Blood website; see the
Supplemental Materials link at the top of the online article).
Immunoblotting and immunohistochemistry
For Western blot analysis, macrophages were plated at 1.5  106/well in
6-well plates and lysed with 50 mM Tris (tris(hydroxymethyl)aminometh-
ane)/HCl, pH7.5, 150 mM NaCl, 1 mM EDTA (ethylenediaminetetraacetic
4352 HELMING et al BLOOD, 15 DECEMBER 2005  VOLUME 106, NUMBER 13
 For personal use only. by guest on January 20, 2014. bloodjournal.hematologylibrary.orgFrom 
acid), 1% Triton X-100, 0.5% NP-40, 1 mM Na3VO4, 1 mM NaF, and
protease inhibitor cocktail (CompleteMini; Roche, Mannheim, Germany).
Lysates were cleared by centrifugation at 1 500g for 5 minutes at 4°C.
Equal amounts of total protein were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and transferred onto polyvinylidene
difluoride membranes (Millipore, Schwalbach, Germany). Membranes
were blocked in 20 mM Tris/HCl, pH 7.5, 137 mM NaCl, and 10% FCS for
4 hours at room temperature followed by an overnight incubation
simultaneously with 2 rabbit anti–phospho signal transducer and
activator of transcription 1 (Stat1) antibodies (Cell Signaling, Up-
state, Dundee, United Kingdom). After incubation with secondary
horseradish peroxidase-conjugated antirabbit antibody (Amersham),
blots were developed using the enhanced chemiluminescence system
(ECLPlus; Amersham).
For Vdr antibody staining, macrophages were grown on glass coverslips
and fixed in ice-cold methanol for 5 minutes and permeabilized in PBS,
0.5% Tween-20 for 5 minutes. Staining was performed using the rat
anti–vitamin D receptor antibody (Research Diagnostics, Concord, MA)
and reagents included in the Ready-to-Use Vectastain Kit (Vector Labs,
Peterborough, United Kingdom) according to the manufacturer’s instruc-
tions with the following modifications. The incubation with the primary
antibody was performed overnight at 4°C and washes were done with PBS,
0.1% Tween-20. Avidin-fluorescein isothiocyanate (Vector) diluted in 10
mM N-2-hydroxyethylpiperazine-N-2-ethanesulfonice acid, 150 mM NaCl
was used for detection. Imaging analysis of confocal microscopy (Figure
4C) was performed with a Zeiss (Go¨ttingen, Germany) LSM 510 inverted
confocal laser scanning microscope using a Plan-Neofluar 100 /1.4
numerical aperture (NA) oil immersion lens. Fixed wild-type and Vdr-KO
cells were excited with an argon laser at 488 nm at low laser intensity
(2.5%), and emission was collected using a 505- to 550-nm bandpass filter
to monitor signals from the immunostaining. The scanning for all images
shown in Figure 4C was done with a pinhole of 203 m and 12-bit data
depth. Light microscopy of Hemacolor- or NBT-stained macrophages
(Figures 2, 3A-B, and 4D) was performed using an inverted Zeiss Axiovert
100 microscope using either an LD Acroplan 40 /0.6 NA objective lens or
a Plan-Neofluar 100 /1.3 NA oil immersion lens, as indicated by the
magnification in the figure legends. A digital AxioCam HRc camera (Zeiss)
was used for documentation.
Results
1,25(OH)2D3 specifically inhibits the listericidal activity of
IFN-–stimulated macrophages by suppression of oxidative burst
Previously, it was demonstrated that exposure of the myeloblastic
cell line HL-60 to 1,25(OH)2D3 can modulate its bactericidal
activity.26 To investigate how 1,25(OH)2D3 might modulate the
bacterial killing activity of mature, primary macrophages, we
examined the effects of 1,25(OH)2D3 on the antimicrobial re-
sponse of murine BMDMs. In addition, we also investigated the
effect of 1,25(OH)2D3 on the bactericidal activity of IFN-–
activated macrophages. To evaluate bactericidal activity, macro-
phages were infected with the intracellular, Gram-positive bacte-
rium L monocytogenes. IFN- is known to be essential for the
control of the intracellular growth of L monocytogenes27,28 BMDMs
were left untreated or treated with 1,25(OH)2D3, IFN-, or both
for 24 and 48 hours and infected with L monocytogenes at an MOI
of 0.1. After infection for 1 and 3 hours, we quantified the
listericidal activity of macrophages by plating and counting
surviving intracellular bacteria. Treatment of macrophages with
1,25(OH)2D3 alone showed no influence on the listericidal
activity of mature macrophages. As expected, IFN- activation of
BMDMs led to decreased amounts of intracellular L monocyto-
genes. Remarkably, even though we were not able to detect any
influence of 1,25(OH)2D3 on the listericidal activity of nonstimu-
lated macrophages, we found that combined treatment with IFN-
and 1,25(OH)2D3 resulted in a significant inhibition of IFN-–
induced listericidal activity (Figure 1). This diminished bacterial
killing activity was observed when macrophages were pretreated
with IFN- and 1,25(OH)2D3 for 24 hours (Figure 1A), but was
more pronounced after pretreatment for 48 hours (Figure 1B). The
increased numbers of intracellular bacteria in 1,25(OH)2D3/IFN-
–treated macrophages were also confirmed at the single-cell level
(Figure 2). We found that 1,25(OH)2D3 suppressed the listericidal
activity of IFN-–stimulated BMDMs in a concentration-depen-
dent manner (Figure 1C), but did not interfere with phagocytotic L
monocytogenes uptake (quantified 20 minutes after infection; data
Figure 1. 1,25(OH)2D3 inhibits the listericidal activity in IFN-–activated
macrophages. (A) BMDMs were cultured in the presence or absence of IFN- and
1,25(OH)2D3 for 24 hours and infected with opsonized L monocytogenes (MOI 0.1) for
1 hour and 3 hours. Extracellular growth of L monocytogenes was prevented by the
addition of gentamicin to the medium and intracellular bacteria were quantified by counting
the number of CFUs in the cell lysates on BHI plates. (B) BMDMs were cultured in the
presence or absence of IFN- and 1,25(OH)2D3 for 48 hours and infected and analyzed
as described in panelA. The data are representative of at least 5 independent experiments.
Similar results were obtained when nonopsonized L monocytogenes was used in the
infection experiments. (C) BMDMs were cultured with IFN- and different concentrations of
1,25(OH)2D3 and infected with L monocytogenes for 3 hours. (D) BMDMs were cultured
with IFN- and 1,25(OH)2D3 and infected with L monocytogenes mutants deficient for
listeriolysin (del hly). Experiments were repeated twice with similar results (A,C-D). Data
are depicted as the meanSEM calculated from triplicate wells (plating was carried out in
duplicate). *P	 .05; Wilcoxon-signed rank test. VitD3 indicates 1,25-dihydroxycholecalcif-
erol. IFN-  500 U/mL, VitD3  40 nM, and treatment was performed for 48 hours except
as otherwise indicated.
Figure 2. 1,25(OH)2D3 inhibits the antilisterial activity in IFN-–activated
macrophages, single-cell analysis. BMDMs were cultured in the presence or
absence of IFN- and 1,25(OH)2D3 and infected with L monocytogenes (MOI  0.1)
for 1 hour and 3 hours. Cells were stained using Hemacolor and analyzed
microscopically and the number of intracellular bacteria per infected cell was
quantified by counting (original magnification  400). Data are presented as the
mean calculated from 50 cells analyzed per condition. *P 	 .05; Mann-Whitney U
test. The data are representative of 3 independent experiments.
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not shown). Taken together, these results demonstrate that
1,25(OH)2D3 is able to specifically inhibit the listericidal activity
of IFN-–stimulated macrophages, whereas 1,25(OH)2D3 has no
obvious effect on resting macrophages. It is known that after
phagocytosis L monocytogenes evades the killing by escaping from
vacuoles into the cytoplasm. To investigate if the 1,25(OH)2D3
treatment affected the ability of the macrophages to kill the bacteria
within the phagosomal vacuole rather than allowing an enhanced
growth of Listeria in the cytoplasm, we infected BMDMs with a
mutant L monocytogenes strain, which is deficient for the listerioly-
sin (hly) gene. The del hly mutants of Listeria are unable to disrupt
the phagosomal membrane because they lack the pore-forming
listeriolysin O, a key factor for host cytosol entry.29 Usually, del hly
mutants are rapidly killed by macrophages due to their inability to
escape from the phagosome. We found that 1,25(OH)2D3 treat-
ment of IFN-–activated macrophages markedly suppressed the
killing of the attenuated del hly mutant (Figure 1D), thus demonstrat-
ing that the 1,25(OH)2D3-mediated inhibition of the listericidal
activity is acting on the phagosome.
We also examined if the 1,25(OH)2D3-mediated suppression
of the IFN-–induced microbicidal activity was specific for
macrophages differentiated from the bone marrow. Using perito-
neal, thioglycolate-elicited macrophages we found that
1,25(OH)2D3 was also able to inhibit IFN-–induced bacterial
killing in these primary cells (data not shown), demonstrating that
the 1,25(OH)2D3-mediated suppression is functional in different
populations of mature macrophages. The effect was observed using
nonopsonized and opsonized Listeria. Under opsonizing conditions
the induced killing activity by IFN- and the inhibition of
bactericidal activity in cells treated with IFN- and 1,25(OH)2D3
was even more pronounced (Figure 1A-B and data not shown).
It has been established that the listericidal activity of macro-
phages depends on the generation of superoxide anion and reactive
nitrogen by the phagocyte oxidase (phox) and the inducible nitric
oxide synthase (iNOS), respectively. We therefore addressed if
1,25(OH)2D3 might inhibit these mechanisms of antimicrobial
activity in IFN-–stimulated macrophages. We first examined the
generation of intracellular superoxide anion radicals (O2  ) after
treatment of BMDMs with IFN- or 1,25(OH)2D3 using the NBT
assay, which is based on the conversion of nitroblue tetrazolium
into blue formazan precipitates. Treatment of macrophages with
1,25(OH)2D3 alone did not influence superoxide anion production
by mature macrophages. As expected, stimulation with IFN-
strongly increased the production of O2  , whereas simultaneous
treatment of BMDMs with IFN- and 1,25(OH)2D3 clearly
inhibited the IFN-–induced generation of superoxide (Figure
3A-C). The suppression of oxidative burst by 1,25(OH)2D3 was
visible with and without addition of PMA, which is a strong
inducer of superoxide anion production.30 As already shown for
bacterial killing (Figure 1C), we found a strong correlation between
the dose of 1,25(OH)2D3 and its suppressive effects on O2 
generation (Figure 3D). Therefore, these data suggest that the
1,25(OH)2D3-mediated inhibition of the oxidative burst is respon-
sible for the diminished killing activity of IFN-–activated macro-
phages. To address this in more detail we quantified the expression
levels of the genes for the different key components of phox by
RT-PCR. Indeed, we found that Cybb expression (encoding gp91phox)
was reduced in IFN-– and 1,25(OH)2D3-treated BMDMs when
compared to macrophages treated with IFN- alone (Figure 3E-F).
Therefore, the inhibition of Cybb expression by 1,25(OH)2D3
seems to be responsible for the suppression of the IFN-–induced
oxidative burst. In contrast, we could not detect any influence of
1,25(OH)2D3 on the generation of nitric oxide in macrophages
pretreated with IFN- and 1,25(OH)2D3 and infected with L
monocytogenes (data not shown). In conclusion, our results suggest
that 1,25(OH)2D3-mediated inhibition of the Cybb expression in
IFN-–activated macrophages leads to a suppression of oxidative
burst and consequently to a reduced killing of intracellular L
monocytogenes.
The suppression of IFN-–induced responses depends
on Vdr expression, localization, and function but is
independent of Stat1
Next, we investigated if the suppressive effects of 1,25(OH)2D3
on IFN-–activated macrophages were dependent on Vdr. We first
examined the mRNA expression of the Vdr gene after 48 hours of
treatment with IFN- and 1,25(OH)2D3 using real-time RT-PCR.
Quantification of Vdr mRNA levels showed that treatment of
BMDMs with 1,25(OH)2D3 but also the activation of macro-
phages with IFN- led to an induction of Vdr expression, which
was 135-fold and 27-fold, respectively (Figure 4A). Interestingly,
simultaneous treatment of macrophages with IFN- and
1,25(OH)2D3 induced a 735-fold and therefore synergistic expres-
sion of Vdr (Figure 4A). This demonstrates that Vdr expression can
Figure 3. 1,25(OH)2D3 inhibits the oxidative burst in IFN-–activated macro-
phages. (A) Intracellular production of superoxide anion was measured by the
conversion of NBT into formazan. BMDMs grown on coverslips were cultured in the
presence or absence of IFN- and 1,25(OH)2D3. NBT (0.1%) with or without PMA
was added for 1 hour and cells were subsequently fixed. Shown is a representative of
3 independent experiments. Original magnification 100. (B) Single cells from panel
A demonstrate specific intracellular formazan precipitation after cellular activation
with PMA or IFN-. Original magnification  200. (C) Quantification of O2 
production. BMDMs were cultured and NBT/PMA was added as described in panel A.
The OD650 of cell homogenates was determined photometrically. (D) BMDMs were
cultured with IFN- and different concentrations of 1,25(OH)2D3. NBT was added
and O2  production was quantified as described. Data are presented as the mean
SEM calculated from triplicate wells; experiments were repeated twice with similar
results (C- D). (E) Semiquantitative Cybb RT-PCR. BMDMs were incubated with
IFN- and VitD3 as described. Cybb- and 
-actin–specific primers were used for
amplification. Shown is a representative of 3 independent experiments. (F) Real-time
Cybb RT-PCR. RNA for analysis was prepared from BMDMs described in panel E
and mRNA expression was normalized as described (  relative mRNA expression).
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be induced in IFN-–stimulated macrophages and that IFN- and
1,25(OH)2D3 are capable of synergistically inducing Vdr expres-
sion after 48 hours. This is in line with our previous observation
that the biologic responses of the IFN- and 1,25(OH)2D3
stimulation, such as the inhibition of listericidal activity and
suppression of the oxidative burst, were most effective after 48
hours of treatment (Figures 1A-B and 3A-C). To investigate the
kinetics of induction of Vdr expression we quantified mRNA levels
at earlier time points of stimulation. We found that the Vdr gene
was synergistically induced after 12 hours of treatment with IFN-
and 1,25(OH)2D3, but not after 6 hours of stimulation (Figure
4B). As a nuclear receptor, the ligand-bound Vdr exerts its effects
by translocation to the nucleus. IFN- treatment of macrophages
showed that most of the detectable Vdr protein was still localized in
the cytoplasm (Figure 4C). In contrast, combined treatment of
BMDMs with 1,25(OH)2D3 and IFN- resulted in an accumula-
tion of Vdr in the nucleus (Figure 4C).
To address if Vdr is indeed functionally involved in the
observed inhibitory effects of 1,25(OH)2D3 on IFN-–stimulated
macrophages, we investigated the induction of oxidative burst and
the listericidal activity in BMDMs obtained from Vdr knockout
mice23 (Vdr-KO). We found that macrophages from Vdr-KO mice
were not able to suppress superoxide anion generation after
treatment with 1,25(OH)2D3 and IFN- (Figure 4D) and were
consequently still able to control the intracellular growth of L
monocytogenes under this condition (Figure 4E). In line with the
previously obtained results, the 1,25(OH)2D3-mediated down-
regulation of Cybb mRNA in IFN-/1,25(OH)2D3-treated macro-
phages was not detectable in Vdr-KO macrophages using real-time
RT-PCR (Figure 4F). These results demonstrate that the observed
suppressive effects of 1,25(OH)2D3 on IFN-–stimulated macro-
phages depend on a functional Vdr.
Because we found that 1,25(OH)2D3 specifically suppressed
IFN-–induced effector mechanisms, we tested if this effect was
dependent on Stat1, an essential component of the classical IFN-
signal transduction pathway. Ligation of the IFN- receptor
triggers activation of Stat1 by phosphorylation on tyrosine 701,
which is a prerequisite for Stat1 nuclear translocation and subse-
quent transcriptional regulation of downstream target genes. We
therefore evaluated the influence of 1,25(OH)2D3 on the amount
of tyrosin 701-phosphorylated Stat1 protein in IFN-–activated
BMDMs. Western blot analysis showed that activation of Stat1 was
not influenced by 1,25(OH)2D3 (Figure 4G).
Stimulation of macrophages with IFN- and 1,25(OH)2D3 leads
to a suppression of several important IFN- target genes
Macrophage activation by IFN- leads to the expression of several
cytokines and chemokines that are key mediators of inflammatory
responses. We therefore investigated if 1,25(OH)2D3 might di-
rectly influence the expression of IFN- target genes in macro-
phages. We initially screened for genes differentially expressed in
BMDMs treated with 1,25(OH)2D3, IFN-, or both using gene
expression profiling. We found that the expression of about 130
genes from more than 400 IFN-–induced genes was significantly
inhibited by simultaneous treatment with 1,25(OH)2D3 (Figure S1
and data not shown). Among those, some were known to be crucial
for IFN-–mediated regulation of innate and adaptive immune
responses. We further quantified and compared the expression of
several identified genes in BMDMs isolated from Vdr-KO and
wild-type (WT) mice using real-time RT-PCR to analyze if the
observed suppression is dependent on Vdr (Figure 5). IFN-
treatment of WT and Vdr-KO macrophages strongly induced
expression of the Th1 cell regulatory chemokines Ccl5 (RANTES),
Cxcl10 (IP-10), Cxcl9 (MIG), and Cxcl16 (SR-PSOX). Double
treatment of macrophages clearly suppressed the induction of these
proinflammatory chemokines in WT macrophages by a factor of 2
to 3, but not in Vdr-deficient macrophages. The same pattern of
Figure 4. The roles of the Vdr and Stat1 for the 1,25(OH)2D3-mediated inhibitory effects. (A) Real-time Vdr RT-PCR. BMDMs were incubated with IFN- or 1,25(OH)2D3
or both for 48 hours, and total RNA was isolated and reverse transcribed. Vdr-specific primers were used for amplification and mRNA expression was normalized as described
(  relative mRNA expression). Synergistic induction of Vdr mRNA by IFN- and 1,25(OH)2D3 was confirmed in 3 additional experiments. (B) Time kinetics of Vdr mRNA
induction. Vdr transcript levels were determined as described in panel A using real-time RT-PCR. (C) Intracellular localization of Vdr protein. BMDMs were cultured as
described in panel A, fixed, and stained with an anti-Vdr antibody (green) and analyzed by confocal microscopy. (D) The inhibition of O2  production by 1,25(OH)2D3 is
dependent on a functional Vdr. BMDMs isolated from WT and Vdr-KO mice were cultured with IFN- and 1,25(OH)2D3 and intracellular production of O2  was analyzed. (E)
The 1,25(OH)2D3-mediated inhibition of listericidal activity depends on the Vdr. BMDMs from WT and Vdr-KO mice were cultured with IFN- and 1,25(OH)2D3 and infected
with opsonized L monocytogenes for 3 hours as described in Figure 1. Data are presented as the mean  SEM calculated from triplicate wells (plating was carried out in
duplicate). (F) Real-time RT-PCR of Cybb. BMDMs (WT and Vdr-KO) were cultured as described in panel A. Cybb-specific primers were used for amplification and mRNA
expression was normalized as described. The experiment was repeated 3 times with similar results. (G) Quantification of activated Stat1 after 1,25(OH)2D3 and IFN-
treatment. BMDMs were cultured as described in panel A and the amount of tyrosine 701-phosphorylated Stat1 protein was determined. *P 	 0.05; Wilcoxon-signed rank test.
Shown is a representative of at least 3 independent experiments (C-G).
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suppression was also detectable for additional IFN-–inducible
genes.Analysis of the interferon regulatory factor 2 (Irf2), interferon-
activated gene 203 (Ifi203), and chemokine receptor 5 (Ccr5)
showed a specific Vdr-dependent inhibition of their expression.
Interestingly, also the IFN-–induced expression of the Fc
receptors 1 and 3 (Fcgr1 and Fcgr3, respectively), which are
key receptors in the development of immune responses and also
the Toll-like receptor 2 (Tlr2) gene, which is important for
recognition of Gram-positive bacteria including L monocyto-
genes, were suppressed by 1,25(OH)2D3, further demonstrat-
ing that the host defense program of IFN-–activated macro-
phages can be notably inhibited by 1,25(OH)2D3 (Figure 5).
Taken together, our results clearly demonstrate that
1,25(OH)2D3 can specifically suppress the IFN- activation of
macrophages via inhibition of important IFN- target genes.
This suppression is strictly dependent on Vdr.
Discussion
We show here that 1,25(OH)2D3 can act as a potent suppressor of
IFN-–induced macrophage activation. Previous studies investigat-
ing the influence of 1,25(OH)2D3 on macrophage function have
mainly analyzed the ability of the steroid to induce differentiation
of myeloid precursors into macrophages or showed influences of
1,25(OH)2D3 on myeloid cell lines and monocytes but did not
address the effects of 1,25(OH)2D3 on mature macro-
phages.15,16,26,31 However, early on it was recognized that mono-
cytes down-regulate the expression of Vdr when they differentiate
into mature macrophages while their capability to synthesize
1,25(OH)2D3 is increased.21 Therefore, it was hypothesized that
the high amounts of 1,25(OH)2D3 that can be released by mature,
activated macrophages would act rather in a paracrine fashion but
not on the 1,25(OH)2D3-secreting macrophage itself.22
Using mature macrophages we show that IFN- activation
together with the simultaneous presence of 1,25(OH)2D3 leads to
a strong synergistic induction of Vdr expression. Under this
condition, 1,25(OH)2D3 is specifically able to suppress major
IFN- responses of macrophages. Among those are the induction of
oxidative burst, microbicidal killing activity, and the expression of
important mediators of inflammation and host defense, including
Ccl5, Cxcl9, Cxcl10, Cxcl16, Fcgr1, Fcgr3, lrf2, lfi203, Ccr5, and Tlr2.
Based on our data, we are suggesting a new negative feedback
loop model on the way by which 1,25(OH)2D3 might regulate
IFN- responses in mature macrophages in an autocrine, dose-
dependent fashion. (1) IFN- stimulation of macrophages induces
the release of 1,25(OH)2D3; however, at these low doses the
steroid has no effect on macrophages because the Vdr is expressed
at low levels. (2) IFN- induces expression of the Vdr, but at low
concentrations of 1,25(OH)2D3 the Vdr protein is predominantly
present in the cytoplasm. (3) Finally, when the 1,25(OH)2D3
accumulates and its concentration passes a certain threshold, Vdr
expression is synergistically induced and the Vdr protein is able to
translocate to the nucleus. This leads to the suppression of
IFN-–induced gene expression in macrophages.
We also found that 1,25(OH)2D3/IFN- treatment decreased
the listericidal activity of macrophages. This correlated with a
strong 1,25(OH)2D3-mediated suppression of oxidative burst,
which was most likely caused by transcriptional inhibition of the
gp91phox (Cybb) component of the phox complex. In addition, other
factors that are affected by 1,25(OH)2D3 might also contribute
together with gp91phox to the decreased listericidal activity. In
contrast to the results presented here, it has been reported for
human fibrosarcoma cell lines and monocytes, that Stat1/Vdr
protein-protein interactions lead to a synergistic effect on IFN-–
mediated transcription mediated by a prolonged phosphorylation of
Stat1.31 In mature murine macrophages, however, we found that
1,25(OH)2D3 had no influence on the amount of tyrosin 701-
phophorylated Stat1 and that 1,25(OH)2D3 could lead to the
inhibition of the listericidal activity independently on Stat1.
Therefore, it is very likely that the underlying mechanisms are
distinct. It is possible that the effect of 1,25(OH)2D3 on IFN-
responses is dependent on the differentiation status of the cell and
therefore markedly differs in myeloid precursors/monocytes and
mature macrophages. Interestingly, similar opposing effects on
monocytes and macrophages have been reported for the “macro-
phage-deactivating” cytokine transforming growth factor 
 1
(TGF-
1). Depending on the state of cellular differentiation and
activation TGF-
1 stimulation leads to proinflammatory or anti-
inflammatory responses. During early stages of inflammation
TGF-
1 acts as a proinflammatory agent on monocytes, whereas
the cytokine has potent immunosuppressive effects on mature
macrophages to mediate the resolution of inflammation (for a
review, see Ashcroft32).
Figure 5. 1,25(OH)2D3 inhibits the expression of numerous IFN-–induced
genes. Real-time quantitative PCR analysis of IFN-–induced gene expression.
BMDMs isolated from WT or Vdr-KO mice were incubated with IFN- or 1,25(OH)2D3
or both. Gene-specific primers were used for amplification and mRNA expression
was normalized as described. Analysis was performed in duplicate and data are
presented as the mean  SEM. Differential gene expression was confirmed at least
in 2 independent experiments.
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We hypothesize that the transcriptional inhibition of IFN-–
induced genes in mature macrophages is mediated by transcrip-
tional crosstalk. Nuclear receptors can act on other transcriptional
pathways either by direct interaction with other transcription
factors or through competition for common coactivators that may
be present in limiting amounts in the cell. It is well established that
the regulation of IFN- responses is dependent on the recruitment
of the coactivators CREB-binding protein (CBP) and p300, which
both interact with Stat1.33 CBP also binds to PU.1, another
transcription factor known to be essential for IFN-–induced gene
transcription.34 Importantly, also Vdr has been reported to interact
with CBP.35 Because we found the Vdr expression to be synergisti-
cally induced by IFN- and 1,25(OH)2D3, it is possible that
increased amounts of Vdr protein preferentially bind to limiting
amounts of CBP or other coactivators, which are essential for
IFN-–induced gene transcription. Inhibition of gene expression
within the immune system by Vdr-mediated transcriptional crosstalk
has been observed in several other studies. In monocytes, DCs, and
T cells it has been demonstrated that 1,25(OH)2D3 can repress the
expression of immunoregulatory genes due to the interaction with
the nuclear factor B and activator protein 1 (AP1) signal
transduction pathways.36-38 Because those pathways are particu-
larly important for the activation of macrophages via Toll-like
receptor signaling, 1,25(OH)2D3 might also interfere with macro-
phage activation by microbial stimuli such as LPS, as already
demonstrated for other nuclear receptors.39,40 We show here that for
IFN-–mediated macrophage activation, expression of the Vdr
gene is synergistically induced by the simultaneous presence of
1,25(OH)2D3. In contrast, when we activated macrophages with
LPS in the presence or absence of 1,25(OH)2D3, we found no
up-regulation of Vdr expression (data not shown). In agreement
with this, we also found no influence of 1,25(OH)2D3 on
LPS-induced NO production and expression of the TNF- gene
(Tnfa; data not shown). We therefore conclude that in mature
macrophages that express low amounts of Vdr, 1,25(OH)2D3
specifically suppresses IFN-–mediated macrophage activation
and this is mediated by up-regulation of Vdr expression. It is well
established that IFN-–induced macrophage activation does not
only lead to enhanced antibacterial activity and enhancement of
inflammatory responses, but also to up-regulation of major histo-
compatibility complex (MHC) class II molecule expression.41
Although we found that listericidal activity and inflammatory gene
expression were suppressed in IFN-–activated macrophages by
1,25(OH)2D3, the expression of MHC class II molecules was
found to be not affected (data not shown).
The suppression of IFN- activation of macrophages by
1,25(OH)2D3 might be an important mechanism to prevent
uncontrolled and excessive reactions in local inflammatory environ-
ments. A tight control of IFN- responses is especially crucial for
the outcome of granulomatous diseases such as tuberculosis and
sarcoidosis. Here, unbalanced IFN- responses can lead to granulo-
matous necrosis and to severe tissue destruction. In addition, it is
known that excessive oxidative burst can lead to DNA damage and
post-granuloma tumor development.42,43 Thus, the synthesis of
1,25(OH)2D3 by granuloma-associated macrophages might be an
important autoregulatory feedback mechanism to prevent exces-
sive inflammation. The suppression of Th1-dominated responses
by 1,25(OH)2D3 during autoimmune diseases in vivo is one of the
well-established features of steroids. Based on our data, we can
extend this general concept of immunosuppression from Th1 cells
and DCs to mature, Th1-activated macrophages. Because macro-
phages also play important roles in several autoimmune diseases,
this may be of special clinical importance.
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